Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses

(2021) Agnes Bonifacius et al.   IMMUNITY

SARS-CoV-2 evolution during treatment of chronic infection

(2021) Steven A. Kemp et al.   NATURE

Covid-19: The E484K mutation and the risks it poses

(2021) Jacqui Wise   BMJ-British Medical Journal

Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia

(2021) Yair Herishanu et al.   BLOOD

SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate

(2020) Manuel Becerra‐Flores et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19

(2020) Yujiro Toyoshima et al.   JOURNAL OF HUMAN GENETICS

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

(2020) Lisa A. Jackson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Convalescent plasma therapy for B-cell depleted patients with protracted COVID-19 disease

(2020) Thomas Hueso et al.   BLOOD

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

(2020) Lennard Y W Lee et al.   LANCET ONCOLOGY

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

(2020) Edward E. Walsh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer

(2020) Victoria A. Avanzato et al.   CELL

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Covid-19 vaccines: delivering protective immunity

(2020) Herb F Sewell et al.   BMJ-British Medical Journal

Different mutations in SARS-CoV-2 associate with severe and mild outcome

(2020) Ádám Nagy et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Depletion of B cells rejuvenates the peripheral B‐cell compartment but is insufficient to restore immune competence in aging

(2019) Irit Avivi et al.   AGING CELL

Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults

(2019) Keisuke Kakisaka et al.   INTERNAL MEDICINE

Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial

(2016) Andrew J. Dunning et al.   Clinical and Vaccine Immunology

Perturbation of the normal immune system in patients with CLL

(2015) F. Forconi et al.   BLOOD

B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome

(2015) M. Colucci et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Outcomes Following Discontinuation ofE. colil-Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia

(2015) Hsiu-Ju Yen et al.   PEDIATRIC BLOOD & CANCER

Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma

(2014) Claudio Fozza et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

(2013) Charlotte Hua et al.   ARTHRITIS CARE & RESEARCH

Absolute Lymphocyte Count Predicts the Response to New Influenza Virus H1N1 Vaccination in Pediatric Cancer Patients

(2012) Annelies M. C. Mavinkurve-Groothuis et al.   Clinical and Vaccine Immunology

Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination

(2012) Robert A. Eisenberg et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment

(2011) O. E. Yri et al.   BLOOD

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab

(2011) U. Arad et al.   VACCINE

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial

(2009) Clifton O. Bingham et al.   ARTHRITIS AND RHEUMATISM

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

(2009) Sander van Assen et al.   ARTHRITIS AND RHEUMATISM

Depletion of peripheral blood B cells with Rituximab and phenotype characterization of the recovering population in a patient with follicular lymphoma

(2009) Abdulmunem M. Abulayha et al.   LEUKEMIA RESEARCH